about
Combination Chemotherapy in Treating Patients With Advanced Colorectal CancerAtrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney CancerNivolumab and Ipilimumab in Treating Patients With Rare TumorsLung-MAP: Durvalumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching BiomarkersNivolumab With or Without Ipilimumab in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube CancerPegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerCombination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch RepairCombination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal CancerPomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple MyelomaPhase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell LymphomaEvaluation of Mammographic Breast Density in Participants With Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502Registry Study of COAGADEX® Patients With Moderate or Severe Hereditary Factor X Deficiency Undergoing Major SurgeryRadiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial CancerDuloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With CancerS0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung CancerAMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine TumorsDasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or GliosarcomaLevonorgestrel in Preventing Ovarian Cancer in Patients at High Risk for Ovarian CancerStudy of Amrubicin in Patients With Small Cell Lung Cancer Refractory or Progressive to Prior TherapyBevacizumab, Radiation Therapy, and Cisplatin in Treating Patients With Previously Untreated Locally Advanced Cervical CancerZoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast CancerRadiation Therapy With or Without Chemotherapy in Patients With Stage I or Stage II Cervical Cancer Who Previously Underwent SurgeryA Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast CancerCalcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination ChemotherapyPatient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical CancerS0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast CancerA Study to Evaluate the Efficacy and Safety of Simtuzumab Combined With Gemcitabine for Metastatic Pancreatic AdenocarcinomaCombination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell LymphomaAlisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin LymphomaSargramostim and/or Vaccine Therapy in Preventing Disease Recurrence in Patients With Advanced MelanomaEarly or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic LeukemiaCombination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by SurgeryZoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone InvolvementChemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung CancerPaclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by SurgeryRuxolitinib Phosphate and Dasatinib or Nilotinib in Treating Patients With Chronic Myeloid LeukemiaGemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract CancersQuality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast CancerTopotecan in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal CancerTemozolomide and Radiation Therapy in Treating Patients With Gliomas
P6153
Q58407403-F19A0D5F-526D-4C6D-AA45-A93D0F2D4F54Q58407407-A42E74D9-3199-4006-9DD2-8633F7CE5DB0Q58407779-5D60E346-2325-486C-A3D2-530B7C9A60E9Q58407878-BF748DC3-A64B-441E-BDD0-917859AF6C23Q58845348-2721E8D1-2357-422E-8900-255CA8BD8C8BQ58845627-38E840C5-D81F-4E73-BB10-5A318133D558Q58845885-8A3559BA-8B17-40FA-BE97-2ADDB2963BCFQ58845987-400B231E-4617-443E-9708-541ABE07C9AEQ61864779-A7D2A8FC-86F3-4FD3-AB2F-18884D095F66Q61865034-9E213601-675F-4EEA-939D-903F6AAD35A2Q61906994-52E6344C-E1DD-4574-863B-F17B9C87CE34Q61909185-4169F68A-F9CA-4C56-9C6D-4A82B9B6377CQ61917860-64DB159E-1005-4863-893F-233E082EA036Q61918146-ECADF831-2BF7-40D9-87AE-B356F7D7B724Q61921083-30194B70-CA75-45E7-9DBB-484C22D94DAFQ61921358-E92EFB2A-CD90-448A-A507-902F49E46E36Q61921666-AFB79978-6D21-4D59-82F3-F06D6C572207Q61924493-2667F244-5D77-4295-9DED-6110C330F596Q61932385-AAE95224-E8D1-424D-9962-B65B6AE17505Q61933599-1C27F048-B4EF-4796-B713-24E9C36FEBCDQ61934392-0E1D71F6-00CB-47F4-8ECC-2F2FE40EB1EDQ61936010-9BEB9665-A26F-4554-A06F-C6D9931BB084Q61936011-2854D055-5C72-4177-A89C-538C260BAAD6Q61936210-F14F8291-2E47-4DFB-9E33-0F111FB252EDQ61936299-BCD7B8F9-EE96-4A40-8453-5B00F35AAFAAQ61936449-9621EAD6-DF32-473A-94D9-8FAB30AFAB51Q61955476-7CA6B958-44FE-46FA-8198-17DCFF906066Q61956013-E5343160-22EE-4625-8971-2A58E4A75C5DQ61956260-5D9A84C3-7C6B-454E-84AE-78C905FA4217Q61970163-61A4C589-AD60-4DD2-BF48-BB2973C25FEFQ61978936-5FB96FE0-2DCD-491E-8DA3-0BB9320A3DAAQ61978971-06E634F5-B7AF-412F-B517-71793DD52EF3Q61980743-469E1A4E-3EFE-43F6-BB18-D8042F255A81Q61981237-7A78EC61-425A-42A1-AB8E-EF7677C02128Q61981377-1D1C4D6A-E0D7-4841-827E-13614E5F3568Q62025050-C39A4411-4E08-4339-9F6A-037B766D4B87Q62031551-182C386E-85AE-4F8C-B143-D9F330FD26B1Q62104750-3CABDAAC-A1EC-4E05-9DF1-B26A3B95DD81Q62104888-9A6E0789-D986-4F82-A3D7-BA2413C2C83DQ62104891-E61B399D-A1B2-4902-8D46-3022C1D8665A
P6153
description
US-amerikanische Organisation
@de
organisatie uit Verenigde Staten van Amerika
@nl
other organization in Kalamazoo, United States
@en
منظمة في كالامازو، الولايات المتحدة
@ar
name
West Michigan Cancer Center
@en
type
label
West Michigan Cancer Center
@en
prefLabel
West Michigan Cancer Center
@en
P131
P2427
grid.430904.a